netic blood diseases(e.g., Sickle Cell Anemia) • Clinical stage: H2 2017 (1" trial, Leukemia with high-risk genetic characteristics) e199R1I'M 2. E-CEL Cellular Therapy • Goal: Accelerate recovery from radiation/chemotherapy • Clinical stage: H1 2018 (1" trial, various cancers) EFTA00292524 Substantial Global Ma